Ultimele actualizari :
08/05/2024
Antiepileptic   Clonazepam  
Injectabil
Soluţie orală
Stabilitatea in solutie Stabilitatea in amestec Factorii care influenteaza stabilitatea Compatibilitate Microunde Bibliografie Pdf
   Formula chimica  

Denumirea comerciala   Denumirea comerciala     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Clonazepamum Polonia
Iktorivil Suedia
Kriadex Mexic
Ravotril Chilli
Rivotril Arabia Saudita, Australia, Columbia, Elvetia, Emiratele Arabe Unite, Franta, Germania, Irlanda, Marea Britanie, Noua Zeelandă, Olanda, Polonia, Spania, Ungaria
Bibliografie   Injectabil   Bibliografie : Clonazepam  
Tip Publicare
939 Ziar Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170.
1189 Ziar Nation RL, Hackett LP, Dusci LJ.
Uptake of clonazepam by plastic intravenous infusion bags and administration sets.
Am J Hosp Pharm 1983 ; 40: 1692-1693.
1246 Ziar Hooymans PM, Janknegt R, Lohman JJHM.
Comparison of clonazepam sorption to polyvinyl chloride-coated and polyethylene-coated tubings.
Pharm Weekbl [Sci] 1990 ; 12: 188-189.
1508 Ziar Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F.
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU.
EJHP 2015 ;22:123-124.
2115 Ziar Schneider JJ, Good Ph, Ravenscroft PJ,.
Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion.
J Pain Symptom Manage 2006 ; 31, 6: 563-567.
2217 Ziar Guchelaar H.J, Hartog M.E.
De stabiliteit van clonazepaminjectievloeistof.
Ziekenhuisfarmacie 1997 ; 13, 1: 21-23.
3184 Laborator
Hyaluronidase (Hyalase®) - Summary of Product characteristics.
CP Pharmaceuticals 2005
3617 Laborator Hyaluronidase (Hyalase®) - Summary of Product Characteristics
Wockhardt 2011
3728 Ziar Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3823 Ziar Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Pharmactuel 2015 ; 48, 3 : 146-152.
3976 Ziar Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218

  Mentions Légales